Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
Roger B. Cohen, MD

Roger B. Cohen, MD Physician

Associate Director of Clinical Research, Abramson Cancer Center Director, Hematology/Oncology Fellowship Program Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Cohen is employed by Penn Medicine.

About Dr. Roger B. Cohen

Recognized by America's Top Doctors 2011 - 2018

Recognized by Best Doctors in America 2011 - 2018

Recognized in Philadelphia magazine's annual Top Docs issues, 2011 - 2018

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties


  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 1986
  • Internal Medicine, 1984
  • Medical Oncology, 1993

Clinical Expertise:

  • Head and Neck Cancer
  • Lung Cancer

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Vetrans Choice Program (6/2018 Not Active)

Education and Training

Medical School: Harvard Medical School
Residency: Mount Sinai Medical Center
Fellowship: Mount Sinai Medical Center
Fellowship: National Cancer Institute


American Association for Cancer Research, National American Society of Clinical Oncology, National Eastern Cooperative Oncology Group, National Heat Biologics, National Millennium Pharmaceuticals Discovery Oncology Scientific Advisory Board, National

Hospital Affiliation

Dr. Cohen is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.


Selected Publications:

Infante Jeffrey R, Cohen Roger B, Kim Kevin B, Burris Howard A, Curt Gregory, Emeribe Ugochi, Clemett Delyth, Tomkinson Helen K, LoRusso Patricia M: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors. Investigational new drugs 35 (5): 576-588,2017.

Bagley Stephen J, Kothari Shawn, Aggarwal Charu, Bauml Joshua M, Alley Evan W, Evans Tracey L, Kosteva John A, Ciunci Christine A, Gabriel Peter E, Thompson Jeffrey C, Stonehouse-Lee Susan, Sherry Victoria E, Gilbert Elizabeth, Eaby-Sandy Beth, Mutale Faith, DiLullo Gloria, Cohen Roger B, Vachani Anil, Langer Corey J: Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 106 : 1-7,2017.

LoRusso Patricia M, Infante Jeffrey R, Kim Kevin B, Burris Howard A, Curt Gregory, Emeribe Ugochi, Clemett Delyth, Tomkinson Helen K, Cohen Roger B: A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors. BMC cancer 17 (1): 173,2017.

Bauml Joshua, Kim Jiyoung, Zhang Xiaochen, Aggarwal Charu, Cohen Roger B, Schmitz Kathryn: Unsupervised exercise in survivors of human papillomavirus related head and neck cancer: how many can go it alone? Journal of cancer survivorship : research and practice 11 (4): 462-468,2017.

Ott P A, Piha-Paul S A, Munster P, Pishvaian M J, van Brummelen E M J, Cohen R B, Gomez-Roca C, Ejadi S, Stein M, Chan E, Simonelli M, Morosky A, Saraf S, Emancipator K, Koshiji M, Bennouna J: Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal. Annals of oncology : official journal of the European Society for Medical Oncology 28 (5): 1036-1041,2017.

Infante Jeffrey R, Patnaik Amita, Verschraegen Claire F, Olszanski Anthony J, Shaheen Montaser, Burris Howard A, Tolcher Anthony W, Papadopoulos Kyriakos P, Beeram Muralidhar, Hynes Scott M, Leohr Jennifer, Lin Aimee Bence, Li Lily Q, McGlothlin Anna, Farrington Daphne L, Westin Eric H, Cohen Roger B: Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer. Cancer chemotherapy and pharmacology 79 (2): 315-326,2017.

Hatten Kyle M, O'Malley Bert W, Bur Andres M, Patel Mihir R, Rassekh Christopher H, Newman Jason G, Cannady Steven B, Chalian Ara A, Hodnett Benjamin L, Lin Alexander, Lukens John N, Cohen Roger B, Bauml Joshua M, Montone Kathleen T, Livolsi Virginia A, Weinstein Gregory S: Transoral Robotic Surgery-Assisted Endoscopy With Primary Site Detection and Treatment in Occult Mucosal Primaries. JAMA otolaryngology-- head & neck surgery 143 (3): 267-273,2016.

Bagley Stephen J, Vitale Steven, Zhang Suhong, Aggarwal Charu, Evans Tracey L, Alley Evan W, Cohen Roger B, Langer Corey J, Blair Ian A, Vachani Anil, Whitehead Alexander S: Pretreatment Red Blood Cell Total Folate Concentration Is Associated With Response to Pemetrexed in Stage IV Nonsquamous Non-Small-cell Lung Cancer. Clinical lung cancer 18 (2): e143-e149,2016.

Bauml Joshua M, Troxel Andrea, Epperson C Neill, Cohen Roger B, Schmitz Kathryn, Stricker Carrie, Shulman Lawrence N, Bradbury Angela, Mao Jun J, Langer Corey J: Scan-associated distress in lung cancer: Quantifying the impact of "scanxiety". Lung cancer (Amsterdam, Netherlands) 100 : 110-3,2016.

Ahn Peter H, Mitra Nandita, Alonso-Basanta Michelle, Palmer James N, Adappa Nithin D, O'Malley Bert W, Rassekh Christopher, Chalian Ara, Cohen Roger B, Lin Alexander: Risk of lymph node metastasis and recommendations for elective nodal treatment in squamous cell carcinoma of the nasal cavity and maxillary sinus: a SEER analysis. Acta oncologica (Stockholm, Sweden) 55 (9-10): 1107-1114,2016.

Academic Contact Info

Division of Hematology-Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-139

Philadelphia, PA 19104
Phone: (215) 662-4469
Patient appointments: 800-789-7366 (PENN)